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Abstract 
Aims: To examine the correlation between the fasting plasma glucose and HbA1c levels using regression equation 
and to assess the average fasting plasma glucose levels for the specific HbA1c (A1C) goals in the patients with diabe‑
tes using each A1C‑and fasting plasma glucose‑based diagnostic criteria.
Methods: This study included data from 4481 participants with A1C and fasting plasma glucose, but with no diabetic 
medications in the Korean National Health and Nutritional Examination Survey 2011. The correlation between fasting 
plasma glucose and A1C was examined using linear regression models.
Results: The A1C levels corresponding to the fasting plasma glucose of 5.5 and 7 mmol/L were 5.75 and 6.42 %. 
However, in the subjects with diabetes diagnosed by the A1C criteria only, 5.5 and 7 mmol/L in the fasting plasma 
glucose predicted A1C of 6.49 and 7.14 % respectively. The average fasting plasma glucose levels to achieve specified 
A1C levels of 5.0–5.9, 6.0–6.9, 7.0–7.9, 8.0–8.9, and 9.0–9.9 % were 5.1, 6.1, 7.7, 8.8 and 11.2 mmol/L, respectively.
Conclusions: The association between A1C and fasting plasma glucose levels is in concordance with the existing 
criteria for diagnosis of diabetes. However, the average fasting plasma glucose concentrations to achieve targeted 
A1C may be lower than those in western populations.
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Background
The incidence of type 2 diabetes is becoming an emer-
gency worldwide, particularly in East Asia, potentially 
reaching a pandemic level in the very near future [1]. 
Although a significant progress has been made in reduc-
ing cardiovascular risk factors among Korean patients 
with diabetes [2], type 2 diabetes creates a considerable 
amount of economic and social burdens in Korea due to 
its long-term and wide-ranging multiple chronic compli-
cations [3, 4]. Therefore, it is important to prevent these 
complications through its early diagnosis and prevention.
Fasting plasma glucose (FPG) should be measured for 
the purpose of screening or diagnosis for impaired fasting 
glucose and diabetes (hyperglycemic states) [5]. However, 
there are certain limitations with it: patients must fast 
more than 8  h before getting screened for diabetes and 
there are numerous factors (e.g., stress, acute illness) that 
can alter glucose concentrations [6]. Hemoglobin A1c 
(A1C) is a standard monitoring test for long-term glyce-
mic control and was recently recommended for the diag-
nosis of diabetes as well although the generalization of 
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diagnosis may still be debated across ethnic groups [7]. 
In 2010, The American Diabetes Association (ADA) has 
recommended the A1C as a diagnostic tool for diabetes 
[8, 9] and in 2011, Korean Diabetes Association (kDa) has 
recommend the A1C as a diagnostic criterion for diabetes 
in clinical practice guidelines for type 2 diabetes [10, 11]. 
Recent study and recommendation showed average fast-
ing glucose concentrations associated with specific A1C 
levels [12, 13]. This result can help the clinicians explain 
the relationship between fasting glucose concentrations 
and specific A1C levels more easily to the patients, but 
no study on this relationship has been made in Korea. 
Although there have been several hospital-based stud-
ies that have evaluated appropriate FPG and A1C cutoff 
levels for identifying patients with hyperglycemic states 
[14–16], it is thought that larger epidemiological studies 
are required to confirm the correlation between A1C and 
FPG for the diagnosis of diabetes in Korean population. 
We conducted this study to examine the relationship 
between the FPG and A1C for diabetes diagnosis (using 
the regression equation) and to access the average FPG 
concentrations associated with specific A1C levels in 
diabetic patients (using each A1c-based and FPG-based 
diagnostic criteria) [4, 11, 17, 18] in the recent national 
representative sample of the Korean adult population.
Methods
The Korea National Health and Nutrition Examination 
Survey (KNHANES), a nationwide cross-sectional sur-
vey and representative of non-institutionalized civilians 
in Korea, is conducted periodically by the Korea Centers 
for Disease Control and Prevention (KCDC). KNHANES 
was initiated in 1998 and was designed to provide com-
prehensive information about Koreans’ health status, 
health behavior, and nutritional status [19]. Data from the 
second year (2011) of KNHANES V (including A1C and 
FPG), was used in this cross-sectional analysis. To pro-
duce an unbiased national estimate, a sample weight was 
assigned for the participating individuals to represent the 
Korean population. Sampling weights were designated by 
the Korean Centers for Disease Control and Prevention 
and were constructed to account for the complex survey 
design, survey non-response, and poststratification [19].
From an initial total of 8518 men and women, 6066 
(2677 men and 3389 women) with A1C and FPG, but 
without previous pharmacological therapy, were evalu-
ated. From these 6066 persons, 1585 were excluded for 
the following reasons: 82 lacked underlying disease infor-
mation; 707 were below 18 years old; 262 had fasting time 
less than 10 h; 366 had anemia defined as a hemoglobin 
value <130 g/L in men (n = 67) and <120 g/L in women 
(n = 299); 8 were pregnant; 14 had the estimated glomer-
ular filtration ratio (eGFR) defined by the modification 
of diet in renal disease (MDRD) study equation less than 
60  mL/min/1.73  m2; 9 had liver cirrhosis; and 137 had 
cancer of different kinds. Therefore, the final number of 
participants used in this analysis was 4481 and the total 
number was estimated to be 29,186,176 after a sam-
ple weight was assigned for the participating individu-
als to represent the Korean population. All examination 
(or testing) protocols were approved by the Institutional 
Review Board of Korea Centers for Disease Control and 
Prevention with each subject providing written informed 
consent before participating and the study protocol 
using this date was reviewed and approved by the insti-
tutional review board of Hallym University Sacred Heart 
Hospital.
Blood samples of all subjects were collected and the 
specimens were immediately centrifuged, aliquoted, fro-
zen at −70 °C, and moved to the central laboratory (Neo-
DIN Medical Institute, Seoul, South Korea), where they 
were analyzed within 24 h. The FPG concentrations were 
measured using an automated analyzer with an enzy-
matic assay (Pureauto S GLU: Daiichi, Tokyo, Japan) 
and the A1C was measured using high performance liq-
uid chromatography (HLC-723G7: Tosoh, Yamaguchi, 
Japan). The thresholds for the diagnosis of diabetes were 
7.0 mmol/L or greater by the FPG criteria, and 6.5 % or 
higher by the A1C criteria.
The statistical analysis was performed using SPSS (Chi-
cago, IL) and weighted to the Korean population to pro-
vide nationally representative estimates. The baseline 
characteristics are presented as the means for continuous 
variables, and proportions for categorical variables. The 
association between fasting blood glucose and A1C was 
examined using linear regression models.
Results
The characteristics of the study population are pre-
sented in Table 1. The study subjects included 1992 men 
(estimated to be 15,168,273) and 2489 women (esti-
mated to be 14,017,903). The average FPG value was 
5.2 ± 0.8 mmol/L (ranging from 2.8 to 16.2 mmol/L) and 
the average A1C value was 5.6 ± 0.5 % (ranging from 3.1 
to 13.6 %). Using data from KNHANES, the results of the 
simple linear regression analysis between the A1C level 
and FPG are summarized in Fig. 1. The prediction model 
between the A1C and FPG in this study population, 
expressed as A1C = 3.146 + 0.468 × FPG (R2 = 0.519, 
p < 0.001), is shown in Fig. 1a. The A1C level increased 
by approximately 0.47 % per the increment of 1.0 mmol/L 
in FPG. In the cases with diabetes diagnosed only by 
the FPG criteria,, the Pearson correlation coefficient (r) 
was 0.726 and the prediction model was expressed as 
A1C = 2.033 + 0.612 × FPG (R2 = 0.686, p < 0.001) while 
the change in A1C per the increment of 1.0  mmol/L in 
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FPG was 0.61 %. The correlation between the A1C level 
and the FPG in participants with diabetes diagnosed only 
by the A1C criteria, shown in Fig. 1b, is expressed as is 
A1C = 3.985 + 0.45 × FPG, (R2 = 0.695, p < 0.001). The 
change in A1C per the increment of 1.0 mmol/L in FPG 
was 0.45 % in these participants.
Based on these calculations, the correspondence of 
A1C to specific FPG were shown in Table  2. We found 
similar results of the linear regression between all study 
population and diabetics diagnosed only by the FPG cri-
teria. However, A1C levels in the subjects diagnosed only 
by FPG criteria are slightly lower than those found in all 
study population. A FPG of 5.5 mmol/L predicted an A1C 
of 5.75 % in the study population and of 5.43 % in the sub-
jects diagnosed only by FBS criteria. A FPG of 7 mmol/L 
also predicted an A1C of 6.42 and 6.32  % respectively. 
However, in the subjects with diabetes diagnosed only by 
the A1C criteria, 5.5 and 7  mmol/L predicted 6.49 and 
7.14  % in the A1C respectively. From these regression 
equations, FPG levels for A1C of 6.5  % were calculated 
at approximately 7.3  mmol/L in diabetics diagnosed by 
the FPG criteria, and 5.5  mmol/L only by A1C criteria. 
Mean fasting plasma glucose concentrations for specific 
A1C groups are summarized in Table 3. The average FPG 
needed to achieve specified A1C levels of lower than 5, 
5.0–5.9, 6.0–6.9, 7.0–7.9, 8.0–8.9, and 9.0–9.9  % and 
more than 10 % were 4.8 mmol/L with 95 % CI 2.8–6.8, 
5.1 mmol/L (3.3–8.9), 6.1 mmol/L (4.0–8.7), 7.7 mmol/L 
(5.4–10.2), 8.8  mmol/L (7.4–12.1) 11.2  mmol/L (6.1–
13.2) and 13.9  mmol/L (11.1–16.2) respectively. These 
results showed that mean FPG concentrations for speci-
fied A1C levels in this study were lower than those in 
previous western studies [12, 13] (Table 3).
Discussion
The results of this study supported a close association 
between A1C and FPG levels for the diagnosis of diabetes 
for the Korean population, which is in concordance with 
the recent recommendations [4, 11, 17, 18]. The A1C lev-
els corresponding to a FPG of 5.5 mmol/L were 5.75 % in 
all study population and 5.43 % in participants with dia-
betes diagnosed by FPG-based diagnostic criteria only. 
The A1C levels corresponding to a FPG of 7  mmol/L 
were also 6.42 and 6.32 % respectively. This suggests that 
the established FPG criteria for the diagnosis of predia-
betes and diabetes is relatively valid in Korean popula-
tion. However, it is thought that there are several issues 
in order to adopt these diagnostic criteria for diabetes in 
Korea.
First, the relationship of A1C and blood glucose with 
the risk of diabetic retinopathy (DR) should be supported 
Table 1 Clinical characteristics of  the study population 
(n = 4481)




Age (years) 48.6 ± 16.3 18 90
Sex (women %) 55.5
Waist circumflex (cm) 81.2 ± 10.1 52 137
Body mass index (kg/m2) 23.6 ± 3.4 13 45
Systolic blood pressure 
(mmHg)
118 ± 17 79 205
Diastolic blood pressure 
(mmHg)
76 ± 10 40 119
FPG (mmol/L) 5.2 ± 0.8 2.8 16.2
A1C (%) 5.6 ± 0.5 3.1 13.6
Total cholesterol (mmol/L) 5.0 ± 0.9 2.4 14.3
Triglyceride (mmol/L) 3.4 ± 2.7 0.2 21.9
LDL cholesterol (mmol/L) 2.9 ± 0.8 0.6 8.1
Fig. 1 Linear regression analysis of fasting plasma glucose and HbA1c in this study population (a) (n = 4481) and in persons with diabetes by 
HbA1c criteria (b) (n = 199)
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by epidemiological studies in Korean population. The 
association between chronic glucose concentrations and 
microvascular complications, particularly DR, has been 
the basis for the diagnosis of diabetes. The diagnostic 
A1C cutoff in diabetes (≥6.5  %) is associated with an 
optimal point for the prevalence of DR, as are the diag-
nostic values for FPG [8]. However, the KDA has adopted 
the diagnostic criteria for type 2 diabetes from the ADA 
recommendation so far because there has been no pro-
spective epidemiological study in Korean population to 
demonstrate an association between blood glucose level 
and the development of DR [11]. A recent study pro-
vided important evidence that A1C threshold of 6.5  % 
is a suitable test for the diagnosis of diabetes mellitus 
in three major Asian ethnic groups, but this study also 
showed that specific A1C levels had different sensitivity 
and specificity in these populations [20]. Therefore, A1C 
should be used thoughtfully and in combination with 
traditional glucose criteria for screening and diagnosis 
of diabetes, although the reasons for these differences 
remain unknown [21]. One Korean community-based 
cross-sectional study showed that the A1C cutoff of 6.5 % 
allowed the proper detection of DM and supported the 
appropriate use of A1C for the diagnosis of diabetes [22]. 
However, the recent nationwide epidemiological study 
from the 2011 KNHANES demonstrated that both FPG 
and A1C levels were closely associated with DR [23]. 
This study showed that the optimal glycemic and A1C 
levels for detecting DR were 6.3  mmol/L for FPG and 
6.2 % for A1C in Korean population suggesting that cur-
rent diabetes diagnostic cutoffsshould be lower for Kore-
ans [23]. The results of our study also show that a FPG 
of 6.3 mmol/L predicted an A1C of approximately 6.1 %, 
supporting the previous study in Korean population.
Second, the patients’ race/ethnicity may influence A1C 
[6, 24, 25]. A recent study showed that African Ameri-
cans have higher A1C levels than non-Hispanic whites 
after adjustment for fasting glucose levels, but had lower 
levels of 1,5-anhydroglucitol suggesting that their post-
prandial glucose levels may be higher [26]. However, 
there was no report for correlation between FPG and 
specific A1C levels in Asian population after 2010 ADA 
indication that A1C should be performed according to 
the method certified by the National Glycohemo-globin 
Standardization Program (NGSP) and standardized to 
the diabetes control and complication trial (DCCT) assay 
[8, 9]. In the present study, the A1C levels correspond-
ing to a FPG of 5.5 and 7 mmol/L were 6.49 and 7.14 % 
respectively in Korean population with newly diagnosed 
diabetes using A1C-based diagnostic criteria only. These 
findings are inconsistent with those in participants who 
are diagnosed by FPG-based diagnostic criteria only in 
this study and are also inconsistent with those in recent 
recommendations [4, 11, 17, 18]. In fact, it is difficult to 
directly compare mean FPG levels for specified A1C lev-
els in the A1c-derived average glucose (ADAG) study and 
our study because the ADAG study was a multicenter 
observational study of serial FPG for specified A1C levels. 
However, it is reported that participants with an elevated 
A1C but “nondiabetic” FPG may have the likelihood of 
showing higher postprandial glucose levels or elevated 
Table 2 A1C estimated from the regression analysis
A1C hemoglobin A1c, FPG fasting plasma glucose








5.3 5.65 5.30 6.39
5.5 5.75 5.43 6.49
5.6 5.77 5.47 6.51
6.3 6.08 5.88 6.81
6.7 6.26 6.11 6.99
7 6.42 6.32 7.14
7.2 6.50 6.42 7.21
7.3 6.55 6.49 7.26
Table 3 Mean fasting plasma glucose levels (95  % CI) 
for specified A1C levels in the ADAG study and KNHANES 
2011
Data are expressed as mean (±SD)
ADAG A1c-derived average glucose, A1C hemoglobin A1c, FPG fasting plasma 
glucose, KNHANES Korea National Health and Nutrition Examination Survey
a The range of specified A1C for this fasting glucose level (6.8 mmol/L) is from 
5.5 to 6.49 %
b Modified from Wei et al. Diabetes Care 2014;37:1048–1051 [12]. These 
estimates are based on the SMBG data from 470 of the ADAG study participants 
(237 with type 1 diabetes and 147 with type 2 diabetes) to determine the 
average fasting blood glucose for specified HbA1c groups
c The range of specified A1C for this fasting glucose level (9.9 mmol/L) is from 
8.0 to 8.5 %
A1C (%) KNHANES 2011a ADAG study [12]b
Mean FPG Mean fasting glucose
Mean (mmol/L) ± SD Range
<5 4.8 ± 0.4 2.8–6.8
5 5.1 ± 0.5 3.3–8.9
6 6.1 ± 0.9 4.0–8.7
6.0–6.4 5.9 ± 0.8 6.8a
6.5–6.9 6.8 ± 1.1 7.9
7 7.7 ± 1.1 5.4–10.2
7.0–7.4 7.5 ± 1.0 8.4
7.5–7.9 8.0 ± 1.1 9.3
8 8.8 ± 1.2 7.4–12.1 9.9c
9 11.2 ± 1.3 6.1–13.2
≥10 13.9 ± 1.8 11.1–16.2
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glycation rates [4] and the results of our study rather sup-
ported these hypothesis in Korean population. Therefore, 
we need to pay more attention that the diabetic patients 
who are diagnosed by A1C-based criteria only have lower 
FPG compared to those who are diagnosed by FPG-based 
criteria only. It also needs to be noted that the patients 
diagnosed by A1C-based criteria only can have higher 
postprandial glucose levels than those who are diagnosed 
by FPG-based criteria only.
Third, it is important that FPG is accurately measured 
for the screening or diagnosis of prediabetes and diabe-
tes, although it was reported that it would be inappropri-
ate to use the fasting glucose criteria alone for screening 
diabetes and the 2-h glucose seems to be a particularly 
important diagnostic tool in Asian populations [27]. In 
fact, most Korean people take regular (biennial) medi-
cal examinations at the National Health Insurance Corp 
including fasting glucose measurement [28]. Any suspi-
cious findings on the results can be sufficient to suggest 
that they need a doctor’s exam or inspections for an 
accurate diagnosis and any necessary treatments. How-
ever, many Korean people think that prediabetes and dia-
betes are screened as a result of these examinations even 
though health screening is not for diagnosis, and they are 
not worried about these hyperglycemic states if normal 
or slightly elevated serum glucose levels are measured. 
Furthermore, many laboratories including the National 
Health Examination measure serum glucose even though 
guidelines rather recommend measurement of plasma 
because large-scale medical checkups require a simple 
and cost-effective sample collection method [6]. Our pre-
vious hospital-based report using data from 2028 persons 
for the evaluation of metabolic abnormalities includ-
ing impaired fasting glucose or dyslipidemia suspected 
through health examinations in the National Health 
Insurance Corp. or by personal medical checkup showed 
that 22.1  % had newly diagnosed diabetes according to 
FPG. Even, among participants with normoglycemia 
according to serum glucose, 14.2 % had newly diagnosed 
diabetes according to FPG diagnostic criteria [29]. It is 
thought that these findings may be one of the important 
reasons why the diagnosis of diabetes, which is the fifth-
leading cause of death in Korea, could be underestimated.
Our study had several limitations. First, this study was 
based on a cross-sectional analysis. Second, participants 
self-reported whether they were taking any glucose-low-
ering medications and from this, recall bias may exist. 
Third, because we did not have the results of 75  g oral 
glucose tolerance test (OGTT), the diagnosis of diabe-
tes among our participants may be underestimated and 
an association between A1C and 2  h postprandial glu-
cose levels in Korean population with newly diagnosed 
diabetes by only A1C-based diagnostic criteria was not 
assessed. Fourth, we excluded participants with ane-
mia but not hemoglobinopathies. This, however, does 
not seem to be an issue as the prevalence of hemoglobi-
nopathy is very low in Korea [30, 31]. Finally, some clini-
cal conditions that could influence the interpretation of 
A1C (such as inflammation or change of diet) were not 
included in this study. Despite these limitations, pre-
sent study, to our knowledge, is the first epidemiological 
report showing the correlation between FPG concentra-
tions and A1C levels after using A1C for the diagnosis of 
diabetes, and the association between the mean FPG con-
centrations and specific A1C levels. However, this study 
also shows a great difference in the correlation between 
FPG and A1C values in the two groups diagnosed only by 
FPG and only by A1C criteria respectively. These results 
require further study to compare the characteristics of 
individuals who are newly diagnosed by either only A1C- 
or FPG-based criteria. Large-scale longitudinal study 
should be made to investigate the association between 
levels of A1C and FPG with incident diabetic retinopa-
thy and to determine the optimal values of A1C and FPG 
for detecting incident diabetic retinopathy in the Korean 
population.
Conclusions
Our study showed that a close association between A1C 
and FPG levels is in concordance with the previous crite-
ria for diagnosis of diabetes. However, the average FPG 
concentrations to achieve targeted A1C in the subjects 
with diabetes diagnosed only by A1C-based criteria may 
be lower than those in western populations. Therefore, 
we need to pay attention that patients diagnosed by A1C-
based criteria only can have higher postprandial glucose 
levels than those who are diagnosed by FPG-based crite-
ria only, in real-life practice.
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